Flow Cytometry Analysis to Identify Human CD8+ T Cells

  • Jacqueline FlynnEmail author
  • Paul Gorry
Part of the Methods in Molecular Biology book series (MIMB, volume 2048)


Flow cytometry is a powerful technique allowing multiparameter detection and quantification of single cells or particles including cell size, granularity, cell components (DNA, mRNA), surface receptors, intracellular proteins, and signaling events. The flow cytometer operates via three main systems: the fluidics, optics, and electronics, which work together to analyze the physical and chemical properties of your sample. The first system, the fluidics, transports your sample in a single stream through the instrument, from the sample tube, pass the lasers, and is either sorted for further experiments or discarded into the waste vessel. The second system, the optical system, is composed of a series of lasers; for excitation of your sample and attached fluorescence antibodies as it passes, a series of lenses; and a detector system. The third system is the electronic component, which enables the photocurrent from the detector system to be changed into electronic pulses to be processed by a computer and analyzed by flow cytometry software. Flow cytometry is thus a powerful technique, which is commonly used to determine the expression of cell surface markers and intracellular molecules to define cells into different populations by fluorescently labeled antibodies.

The staining procedure outlined below creates a single-cell suspension for staining with a panel of flow cytometry antibodies, which target different surface markers, to identify an array of cell types. After staining the sample is loaded into the flow cytometer, where the fluorescently labeled cells are excited as they pass by the laser emitting light at various wavelengths which are detected by the flow cytometer. Each fluorescent antibody has its own excitation and emission spectrum allowing the use of multiple antibodies. However, the emission spectrums of different fluorochromes can overlap each other, called spectral overlap. Thus, it is important to have good compensation controls to eliminate any antibody spillover.

The staining methods from this technique can be used for different cell types by changing the surface marker targeted by the flow antibody. It is also important to use knowledge of the density of surface molecule for detection and brightness of fluorochrome to guide antibody selection and also to titrate all antibodies prior to use.

This chapter’s protocol has been designed specifically for detection of human CD8+ T cells defining the activation status of the cells by surface marker phenotyping.

Key words

CD8+ T cells Flow cytometry Activation Naïve T cells Memory T cells CD markers T cells 


  1. 1.
    Gulzar N, Copeland KF (2004) CD8+ T-cells: function and response to HIV infection. Curr HIV Res 2(1):23–37CrossRefGoogle Scholar
  2. 2.
    Berg RE, Forman J (2006) The role of CD8 T cells in innate immunity and in antigen non-specific protection. Curr Opin Immunol 18(3):338–343CrossRefGoogle Scholar
  3. 3.
    Barber DL, Wherry EJ, Ahmed R (2003) Cutting edge: rapid in vivo killing by memory CD8 T cells. J Immunol 171(1):27–31CrossRefGoogle Scholar
  4. 4.
    Bohana-Kashtan O, Civin CI (2004) Fas ligand as a tool for immunosuppression and generation of immune tolerance. Stem Cells 22(6):908–924CrossRefGoogle Scholar
  5. 5.
    Flynn JK, Dore GJ, Hellard M, Yeung B, Rawlinson WD, White PA et al (2011) Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users. J Viral Hepat 18(8):549–561CrossRefGoogle Scholar
  6. 6.
    Cashin K, Paukovics G, Jakobsen MR, Ostergaard L, Churchill MJ, Gorry PR et al (2014) Differences in coreceptor specificity contribute to alternative tropism of HIV-1 subtype C for CD4 + T-cell subsets, including stem cell memory T-cells. Retrovirology 11(1):97CrossRefGoogle Scholar
  7. 7.
    Flynn JK, Gorry PR (2014) Stem memory T cells (TSCM)—their role in cancer and HIV immunotherapies. Clin Transl Immunology 3:e20CrossRefGoogle Scholar
  8. 8.
    Flynn JK, Paukovics G, Cashin K, Borm K, Ellett A, Roche M et al (2014) Quantifying susceptibility of CD4+ stem memory T-cells to infection by laboratory adapted and clinical HIV-1 strains. Viruses 6(2):709–726CrossRefGoogle Scholar
  9. 9.
    Flynn JK, Paukovics G, Moore MS, Ellett A, Gray LR, Duncan R et al (2013) The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsets. Virology 442(1):51–58CrossRefGoogle Scholar
  10. 10.
    Mahnke YD, Brodie TM, Sallusto F, Roederer M, Lugli E (2013) The who's who of T-cell differentiation: human memory T-cell subsets. Eur J Immunol 43(11):2797–2809CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Rheumatology Research Group, Centre for Inflammatory Diseases, School of Clinical Sciences at Monash HealthMonash UniversityMelbourneAustralia
  2. 2.School of Health and Biomedical SciencesRMIT UniversityMelbourneAustralia
  3. 3.Burnet InstituteMelbourneAustralia

Personalised recommendations